Efficacy of tobramycin aerosol in nasal polyposis

European Annals of Otorhinolaryngology, Head and Neck Diseases

Volumn 132, Issue 3, 2015, Pages 119-123

  Bonfils, P ^a   Escabasse, V ^b   Coste, A ^b   Gilain, L ^c   Louvrier, C ^c   Serrano, E ^d   De Bonnecaze, G ^d   Mortuaire, G ^e   Chevalier, D ^e   Laccourreye, O ^a   Mainardi, J L ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^d SERVICE DE PNEUMOLOGIE   (France)

^e UNIV LILLE   (France)

Author keywords

Aerosol therapy; Ethmoidectomy; Nasal polyposis; Tobramycin

Indexed keywords

TOBRAMYCIN; ANTIINFECTIVE AGENT; ISOTONIC SOLUTION; NOSE SPRAY;

ADULT; AEROSOL; AGED; ARTICLE; ASTHMA; BRONCHITIS; COMPARATIVE STUDY; CONTROLLED STUDY; COUGHING; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHEMA; FACE PAIN; FEMALE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEBULIZATION; NEBULIZER; NOSE CAVITY; NOSE POLYP; OTALGIA; OTITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SNEEZING; CLINICAL TRIAL; DRUG EFFECTS; FRANCE; MICROBIOLOGY; MIDDLE AGED; NASAL POLYPS; NOSE MUCOSA; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; FRANCE; HUMANS; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; NASAL SPRAYS; PROSPECTIVE STUDIES; TOBRAMYCIN; TREATMENT OUTCOME;

EID: 84930928681     PISSN: 18797296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anorl.2015.03.008     Document Type: Article

References (11)

1. Casale M, Pappacena M, Potena M, et al. Nasal polyposis: From pathogenesis totreatment, an update. Inflamm Allergy Drug Targets 2011;10:158-63.
2. Bonfils P. Polypose naso-sinusienne. EMC; 2011. p. 23 [20-395-A-10].
3. Ramakrishnan VR, Feazel LM, Abrass LJ, et al. Prevalence and abundance ofStaphylococcus aureus in the middle meatus of patients with chronic sinusitis, nasal polyps, and asthma. Int Forum Allergy Rhinol 2013;3:267-71.
4. Cleland EJ, Bassiouni A, Wormald PJ. The bacteriology of chronic rhinosinusitisand the pre-eminence of Staphylococcus aureus in revision patients. Int ForumAllergy Rhinol 2013;3:642-6.
5. Day N, Mainardi JL, Malinvaud D, et al. Bacteriological study of ethmoidspecimens from patients with nasal polyposis after ethmoidal surgery. AnnOtolaryngol Chir Cervicofac 2009;126:196-202.
6. Dautzenberg B, Bonfils P, Diot P, et al. Best clinical practices for aerosol neb-ulization approved by the National Meeting on Nebulization, Paris, 4-5 April1997. Ann Otolaryngol Chir Cervicofac 2000;117:327-32.
7. Vecellio L, De Gersem R, Le Guellec S, et al. Deposition of aerosols delivered bynasal route with jet and mesh nebulizers. Int J Pharm 2011;407:87-94.
8. Bonfils P, Halimi P, Malinvaud D. Adrenal suppression and osteo-porosis after treatment of nasal polyposis. Acta Otolaryngol 2006;126:1195-200.
9. Snidvongs K, Kalish L, Sacks R, et al. Sinus surgery and delivery methodinfluence the effectiveness of topical corticosteroids for chronic rhinosi-nusitis: Systematic review and meta-analysis. Am J Rhinol Allergy 2013;27:221-33.
10. Scheinberg P, Shore E. A pilot study of the safety and efficacy oftobramycin solution for inhalation in patients with severe bronchiectasis. Chest2005;127:1420-6.
11. Mainz JG, Schädlich K, Schien C, et al. Sinonasal inhalation of tobramycinvibrating aerosol in cystic fibrosis patients with upper airway Pseudomonasaeruginosa colonization: Results of a randomized, double-blind, placebo-controlled pilot study. Drug Des Devel Ther 2014;8:209-17.